DISHMAN CARBOGEN AMCIS
Back to Balance Sheet
|
DISHMAN CARBOGEN AMCIS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹423 Cr | ₹427 Cr | ₹443 Cr | ₹415 Cr | ₹394 Cr |
What is the latest Contingent Liabilities ratio of DISHMAN CARBOGEN AMCIS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹423 Cr |
| Mar2024 | ₹427 Cr |
| Mar2023 | ₹443 Cr |
| Mar2022 | ₹415 Cr |
| Mar2021 | ₹394 Cr |
How is Contingent Liabilities of DISHMAN CARBOGEN AMCIS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹423 Cr | -0.91 | |
| Mar2024 | ₹427 Cr | -3.52 | |
| Mar2023 | ₹443 Cr | 6.70 | |
| Mar2022 | ₹415 Cr | 5.24 | |
| Mar2021 | ₹394 Cr | - | |
Compare Contingent Liabilities of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹3,033.3 Cr | 3% | 0.4% | -22.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | 3% |
0.4% |
-22.8% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses